Literature DB >> 8997439

Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia.

V Kirstilä1, M Lenander-Lumikari, E Söderling, J Tenovuo.   

Abstract

This study evaluates the effects of two oral hygiene products containing nonimmunoglobulin antimicrobial agents on whole saliva and on subjective oral symptoms in patients with xerostomia. Twenty patients used a lactoperoxidase-system-containing toothpaste (Biotene) combined with the use of a mouthrinse (Biotene), comprising also lysozyme and lactoferrin, for 4 weeks. Saliva samples were collected at base line, after 4 weeks' use of the products, and at the end of a 4-week washout period. Samples were analyzed for selected biochemical and microbiologic factors. The effects on subjective oral symptoms were also recorded. A 4-week daily use of toothpaste and mouthrinse relieved the symptoms of oral dryness in 16 patients. The levels of salivary hypothiocyanite, lysozyme, lactoferrin, or myeloperoxidase activity did not change, but there was a significant decrease in salivary pH (P < 0.05), total peroxidase activity (P < 0.05), and total protein content (P = 0.01). In patients with the lowest salivary flow rates (n = 5) a significant (P > or = 0.04) increase was detected in salivary hypothiocyanite concentrations. No major changes occurred in salivary microflora. The products relieved subjective oral symptoms in most xerostomic patients, but this was not necessarily related to the presence of antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997439     DOI: 10.3109/00016359609003557

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  8 in total

1.  Cytotoxic effects of a chlorhexidine mouthwash and of an enzymatic mouthwash on human gingival fibroblasts.

Authors:  Ana Sofia Coelho; Mafalda Laranjo; Ana Cristina Gonçalves; Anabela Paula; Siri Paulo; Ana Margarida Abrantes; Francisco Caramelo; Manuel Marques Ferreira; Mário Jorge Silva; Eunice Carrilho; Maria Filomena Botelho
Journal:  Odontology       Date:  2019-10-17       Impact factor: 2.634

2.  Efficacy of GUM® Hydral versus Biotène® Oralbalance mouthwashes plus gels on symptoms of medication-induced xerostomia: a randomized, double-blind, crossover study.

Authors:  Anna Greta Barbe; Yasmin Schmidt-Park; Stefanie Hamacher; Sonja Henny Maria Derman; Michael Johannes Noack
Journal:  Clin Oral Investig       Date:  2017-03-28       Impact factor: 3.573

Review 3.  Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors:  W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

4.  Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.

Authors:  Ardita Aliko; Adem Alushi; Argjend Tafaj; Ramazan Isufi
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

5.  Oral peroxidases: From antimicrobial agents to ecological actors (Review).

Authors:  Philippe Courtois
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

6.  Protease inhibitor concentrations in the saliva of individuals experiencing oral dryness.

Authors:  Kenkichi Yamamoto; Makiko Hiraishi; Mai Haneoka; Hidetake Fujinaka; Yoshitaka Yano
Journal:  BMC Oral Health       Date:  2021-12-20       Impact factor: 2.757

7.  Ex vivo decontamination of yeast-colonized dentures by iodine-thiocyanate complexes.

Authors:  Sarra Sebaa; Maxime Faltot; Sandra De Breucker; Zahia Boucherit-Otmani; Françoise Bafort; Jean-Paul Perraudin; Philippe Courtois
Journal:  Clin Cosmet Investig Dent       Date:  2018-07-25

8.  Effects of a Novel Formulation on Oral Biofilm, pH Buffering, and Gingival Health in Patients with Dry Mouth.

Authors:  Thair Takesh; Jessica Ho; Miracle Vania Firmalino; Delaney Islip; Afarin Anbarani; Petra Wilder-Smith
Journal:  Int J Dent       Date:  2018-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.